COVID -19 Impact On The Sterile Filtration Research Technology Market:
Countries are in a global race to develop and mass-produce an efficient vaccine to fight the deadly coronavirus disease. The economic and social burden of pandemics has prompted government bodies to increase funding for vaccine development on a global scale.
# The German government’s Federal Ministry of Education and Research provided ~USD 200 million (GBP 157.0 million) to support CEPI’s (Coalition for Epidemic Preparedness Innovation) plan of developing a COVID-19 vaccine.
# The EU public-private partnership, the Innovative Medicines Initiatives (IMI), will be allocating ~USD 127 million for research on diagnostics, therapeutics, and vaccine development for COVID-19. The European Commission committed USD 78 million, and USD 49 million will be provided by the pharmaceutical industry, IMI-associated partners, and other organizations involved with the projects.
# The US Congress has passed an emergency response bill of USD 8.3 billion for prevention efforts and the development of vaccines for COVID-19.
# According to the UK government, the country has invested USD 82.0 million for research on coronavirus and the development of vaccines for COVID-19.
Download PDF [email protected]
Expected Revenue Growth:
The global sterile filtration market size is projected to reach USD 7.6 billion by 2025 from USD 5.1 billion in 2020, at a CAGR of 8.2%. Growth of this market is driven by factors such as advantages of sterile filters over non-sterile filters, the growing demand for pure water in the end-user market, increasing adoption of single-use technologies, and rising focus on the development of large biopharmaceutical drugs. The manufacturing and use of advanced filters for sterile filtration and the untapped potential in emerging countries offer a significant scope of growth in the sterile filtration market.
The cartridge filters segment accounted for the largest share of the global sterile filtration market in 2019.
Based on product, the Sterile Filtration Research Technology Market is segmented into cartridge filters, capsule filters, membranes, syringe filters, bottle-top & table-top filtration systems, and accessories. In 2019, the cartridge filters segment accounted for the largest share of the sterile filtration market. The large share of this segment can primarily be attributed to the increasing use of different types of cartridge filters for larger processes requiring more filtration area and/or lower unit operating costs.
The polyethersulfone (PES) segment accounted for the largest share of the global sterile filtration market in 2019.
Based on membrane type, the sterile filtration market is segmented into polyethersulfone (PES), polyvinylidene difluoride (PVDF), nylon, polytetrafluoroethylene (PTFE), mixed cellulose ester & cellulose acetate (MCE & CA), and other materials. In 2019, the polyethersulfone (PES), segment accounted for the largest share of the plaque modification devices market, mainly due to the increasing incidence of atherosclerosis as a result of the rising global prevalence of obesity.
North America accounted for the largest share of the sterile filtration market in 2019
Based on the region, the Sterile Filtration Research Technology Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the sterile filtration market in 2019. The large share of the North American region can be attributed to a large number of pharmaceutical and biotechnology and food & beverage companies in the region, the presence of a well-established healthcare market, and stringent regulations for the pharmaceutical industry.
Request Sample [email protected]
Key Market Players:
Key players in the Sterile Filtration Research Technology Market are Merck KGaA (Germany) is the largest player in the global sterile filtration market. The company has expanded its position as the most profitable technology and solutions supplier in the sterile filtration industry by offering leading-edge products for biotech & pharmaceutical companies and for the advancement of cell and gene therapy. The company also adopts organic strategies such as product launches and expansions to maintain its position in this market. Some of the major players in the sterile filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), 3M (US), Parker Hannifin Corporation (US, Sterlitech Corporation (US), Alfa Laval AB (Sweden), and Thermo Fisher Scientific (US).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441